Company Directory

Company Directory

Company Directory - Omnicare

Company Details - Omnicare

Omnicare Logo

Omnicare

Website

Omnicare is a pharmacy services provider and a subsidiary of CVS Health. The company specializes in serving long-term care facilities, delivering pharmaceutical care and related services to enhance the health and well-being of residents.

CCI Score

CCI Score: Omnicare

-53.46

0.02%

Latest Event

Omnicare Faces Liability for Unlawful Drug Dispensing

A jury found Omnicare liable for dispensing drugs without valid prescriptions to elderly and disabled individuals in assisted living and long-term care facilities, contributing to a legal charge that impacted CVS Health's quarterly guidance.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Use Your Voice
OTHER TOOLS
Investigate
Share the Score
SUPPORT CCI

QUISLING

Omnicare is currently rated as a Quisling.

-44 to -59 CCI Score
These companies are fully aligned with authoritarian regimes. They not only support but also enforce oppressive policies, playing a significant role in the regime’s operational apparatus and contributing directly to its consolidation of power.

Latest Events

  • Omnicare Faces Liability for Unlawful Drug Dispensing Logo
    MAY
    01
    2025

    A jury found Omnicare liable for dispensing drugs without valid prescriptions to elderly and disabled individuals in assisted living and long-term care facilities, contributing to a legal charge that impacted CVS Health's quarterly guidance.

  • Omnicare Faces Massive Damages Verdict in False Claims Act Case Logo
    APR
    30
    2025

    A federal jury in New York rendered one of the largest damages verdicts in a False Claims Act case against Omnicare for fraudulent dispensing practices to long-term care residents. The company, a subsidiary of CVS Health, expressed disappointment and announced plans to appeal the decision.

  • -70

    Business Practices and Ethical Responsibility

    May 1

    Omnicare's involvement in fraudulent billing practices—dispensing drugs without valid prescriptions and submitting false claims—demonstrates significant ethical failings. The massive damages verdict and the planned appeal highlight practices that undermine public trust and exploit vulnerable populations in long-term care settings.

    Long-term care pharmacy Omnicare sees 'one of the largest damages verdicts' in False Claims Act case, plans appeal

  • Omnicare Found Liable for Overbilling in Long-Term Care Logo
    APR
    30
    2025

    A federal jury found Omnicare liable for improperly billing Medicare, Medicaid, and TRICARE by submitting over 3 million false claims from 2010 to 2018, resulting in damages exceeding $135 million, with potential penalties tripling under the False Claims Act. The verdict, described as one of the largest in such a case, has led to an appeal by CVS Health.

  • -80

    Business Practices and Ethical Responsibility

    May 1

    Omnicare's involvement in submitting over 3 million false claims represents a severe breach of ethical business practices, exploiting vulnerable populations in long-term care and misappropriating federal funds meant for essential healthcare services. This conduct undermines public trust in corporate responsibility and disregards the welfare of marginalized groups.

    Long-Term Care Pharmacy Omnicare Hit With 'Largest Damages Verdict ...

  • Omnicare Found Liable for False Billing Claims Logo
    APR
    29
    2025

    A jury found Omnicare liable for billing Medicare, Medicaid, and Tricare for false claims, resulting in $135.6 million in damages with potential tripled penalties under the False Claims Act. The verdict implicates the company's unethical business practices and fraudulent billing procedures.

  • -70

    Business Practices and Ethical Responsibility

    May 1

    The jury's verdict holding Omnicare liable for filing false claims against government healthcare programs reflects a serious breach of ethical business practices. This fraudulent billing undermines public trust in essential social services and represents corporate behavior that prioritizes profit over ethical responsibility.

    DOJ Says Jury Found CVS's Omnicare Liable for False Claims

  • Jury Verdict: Omnicare Found Guilty of Fraudulent Billing Logo
    APR
    29
    2025

    A New York federal jury returned a verdict awarding $136M against Omnicare, a CVS Health subsidiary, for illegally billing the federal government under the False Claims Act, highlighting significant unethical business practices.

  • -70

    Business Practices and Ethical Responsibility

    May 1

    The $136M jury verdict against Omnicare for illegally billing the federal government reflects a serious breach of ethical business practices. Such fraudulent behavior undermines public trust and democratic accountability by diverting government funds and potentially enabling authoritarian practices by weakening institutional oversight. This action is thus rated negatively within the Business Practices and Ethical Responsibility category.

    Omnicare Hit With $136M Jury Verdict For Bilking Feds

  • Allegations of Disguised Kickbacks via Charitable Donations Logo
    OCT
    01
    2021

    A federal judge allowed whistleblower allegations to proceed that Omnicare funneled payments to nursing home owners, disguising them as charitable contributions made through its nonprofit arm, raising concerns about unethical business practices.

  • -60

    Business Practices and Ethical Responsibility

    May 1

    The judge’s ruling to allow charges based on allegations that Omnicare used its nonprofit arm to disguise nursing home kickbacks as charitable contributions reflects a serious lapse in ethical business practices. Such behavior undermines corporate transparency and accountability, particularly in a sector serving vulnerable populations, and can be seen as exploiting trust for profit.

    Charges that Omnicare disguised nursing home kickbacks as charitable contributions can proceed, federal judge rules

  • DOJ Settlement for Omnicare False Claims Allegations Logo
    MAR
    12
    2015

    Omnicare, a major provider of pharmacy services to nursing homes, agreed to pay $124.24 million to settle allegations of providing improper financial incentives to skilled nursing facilities in order to secure contracts for supplying drugs under Medicare and Medicaid. The settlement resolved claims that the company submitted false claims by entering into below-cost contracts, as part of a broader effort to combat healthcare fraud.

  • -70

    Business Practices and Ethical Responsibility

    May 1

    Omnicare engaged in unethical business practices by offering improper financial incentives to nursing homes, thereby undermining public trust and exploiting vulnerable elderly populations. Such practices erode the integrity of healthcare services and run counter to principles of ethical responsibility and transparency.

    Justice Department Settles With Omnicare, Inc. For $124 Million To Resolve False Claims Allegations

  • US Files Lawsuit Against Omnicare Over Kickback Allegations Logo
    DEC
    22
    2014

    The U.S. government has filed a civil False Claims Act lawsuit against Omnicare Inc., alleging that the company solicited and received millions of dollars in kickbacks from Abbott Laboratories. The suit claims that Omnicare used these kickbacks to promote the prescription drug Depakote in nursing homes, potentially compromising the care of elderly patients.

  • -80

    Business Practices and Ethical Responsibility

    May 1

    The allegations that Omnicare solicited and accepted kickbacks from a pharmaceutical manufacturer to influence drug prescriptions reflect unethical business practices. These practices not only compromise patient care for a vulnerable population but also undermine public trust in healthcare services, marking a clear violation of ethical standards.

    United States Files Suit Against Omnicare Inc. for Accepting Kickbacks from Drug Manufacturer to Promote an Anti-Epileptic Drug in Nursing Homes

  • Omnicare Settlement for False Claims Allegations Logo
    AUG
    29
    2014

    Omnicare, the nation’s largest nursing home pharmacy provider, agreed to pay $124.24 million to settle allegations that it offered improper financial incentives to skilled nursing facilities. These incentives allegedly induced facilities to select Omnicare for drug supply contracts for Medicare and Medicaid beneficiaries, resulting in false claims submitted to federal health care programs.

  • -75

    Business Practices and Ethical Responsibility

    May 1

    The settlement highlights unethical business practices where Omnicare allegedly engaged in deceptive financial incentives to secure contracts, undermining trust in public health programs and exploiting vulnerable elderly populations. This behavior is deeply problematic as it harms marginalized communities and compromises the integrity of healthcare services.

    Nation’s Largest Nursing Home Pharmacy Company to Pay $124 Million to Settle Allegations Involving False Billings to Federal Health Care Programs

Industries

621610
Home Health Care Services
624120
Services for the Elderly and Persons with Disabilities
446110
Pharmacies and Drug Stores
621990
All Other Ambulatory Health Care Services